Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Placebo Controlled Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine in Subjects With Hypertension Requiring Antihypertensive Therapy

NCT02172040 is registered in ClinicalTrials.gov with Kitov Pharmaceuticals, Ltd. as lead sponsor.

NCT NCT02172040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02172040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Placebo Controlled Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine in Subjects With Hypertension Requiring Antihypertensive Therapy
Lead sponsor
Kitov Pharmaceuticals, Ltd.
Phase
Phase 3
Overall status
Completed
Start date
June 26, 2014
Completion date
November 19, 2015
Enrollment
152 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension